Results 121 to 130 of about 835,228 (309)
THE ELECTRONIC SIGNATURE. ITS VALORIZATION AS A EVIDENTIARY MEANS IN NATIONAL OR INTERNATIONAL PENDING CASES JUDGED IN COURTS [PDF]
In the European Union states, there is a variety of legal norms regulating the electronic signature, fact which led to the initiative of the European Commission to harmonize the incidental dispositions in the legislation of the member states to eliminate
. George Măgureanu
core
Cryptanalysis of Nonrepudiable Threshold Proxy Signature Schemes with Known Signers [PDF]
, 2009 [[abstract]]In 2000, Hwang et al. proposed a nonrepudiable threshold proxy signature scheme to improve Sun’s scheme. In this paper, a new attack is proposed to show that, both in Hwang et al.’s and Sun’s schemes, the threshold proxy signatures can be ...
Hwang;Shin-Jia and Chen;Chiu-Chin
core
Molecular Oncology, EarlyView.Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Automatic signature verification system [PDF]
, 2013 Philosophiae Doctor - PhDIn this thesis, we explore dynamic signature verification systems. Unlike other signature models, we use genuine signatures in this project as they are more appropriate in real world applications.
Malladi, Raghuram
core
Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining
Molecular Oncology, EarlyView.IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis +3 more
wiley +1 more source
Molecular Oncology, EarlyView.Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
MITF maintains genome stability in nonmelanocyte lineages
Molecular Oncology, EarlyView.MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
Cryptanalysis of The Hwang-Shi Proxy Signature Scheme
, 2012 [[abstract]]Recently, Hwang and Shi proposed an efficient proxy signature scheme without using one-way hash functions. In their scheme, an original signer needn't send a proxy certificate to a proxy signer through secure channels.
黃明祥;Hwang, Min-Shiang
core
Cryptanalysis of A New Multi-Proxy Multi-Signature Scheme [PDF]
, 2009 [[abstract]]Recently, Hwang and Chen [5] proposed a variation of proxy signature scheme called the multi-proxy multi-signature scheme. In their scheme, an authorized group of proxy signers is allowed to sign message on behalf of a group of original ...
孫宏民;謝濱燦;林宸堂
core